US74365U1079 - Common Stock
PROTARA THERAPEUTIC INC
NASDAQ:TARA (4/22/2024, 10:03:44 AM)
2.94
+0.3 (+11.36%)
Protara Therapeutics, Inc. is a clinical-stage company engaged in developing treatments for rare and specialty diseases with significant unmet needs. The company is headquartered in New York City, New York and currently employs 25 full-time employees. The company went IPO on 2014-10-22. The firm is focused on identifying therapies for the treatment of cancer and rare diseases. The firm's pipeline includes TARA-002 and IV Choline Chloride. The firm's lead product pipeline is TARA 002 for the treatment of non-muscle invasive bladder cancer (NMIBC) and Lymphatic Malformations (LMs). TARA 002 is a cellular therapy based on OK-432, also known as Picibanil, which is derived from a genetically distinct strain of Streptococcus Pyogenes. The Company’s IV choline chloride is an investigational, intravenous (IV) phospholipid substrate replacement therapy, which is in development for patients receiving parenteral nutrition (PN) who have intestinal failure-associated liver disease (IFALD).
PROTARA THERAPEUTIC INC
345 Park Avenue South, 3rd Floor
New York City NEW YORK 10010
P: 16468440337
CEO: Jesse Shefferman
Employees: 25
Website: https://protaratx.com/
Gapping stocks in Monday's session
Anticipated net proceeds, along with existing cash and cash equivalents, expected to extend cash runway into 2026...
New development pathway significantly expands addressable patient population for IV Choline ChlorideIV Choline Chloride has the potential to become the...
TARA-002 demonstrated a complete response rate of 43% at three months in BCG-Unresponsive/Experienced patients in ongoing NMIBC programTARA-002...
If you want extreme gains, you’ve got to take extreme risks. These stocks to help you retire on a private island might help.
Preliminary results from ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS on track for 1H 2024Preliminary data from ADVANCED-2 trial...
Here you can normally see the latest stock twits on TARA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: